Prognostic significance of troponin increment after percutaneous coronary intervention: A retrospective study.

Li, Ya; Li, Duanbin; Zhao, Liding; Xu, Tian; Lv, Qingbo; He, Jialin; Wang, Yao; Zhang, Wenbin

Li, Ya; Li, Duanbin; Zhao, Liding; Xu, Tian; Lv, Qingbo; He, Jialin; Wang, Yao; Zhang, Wenbin.

Afiliação

Li Y; Department of Cardiovascular Diseases, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Li D; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, China.
Zhao L; Department of Cardiovascular Diseases, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Xu T; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, China.
Lv Q; Department of Cardiovascular Diseases, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
He J; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, China.
Wang Y; Department of Cardiovascular Diseases, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Zhang W; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, China.

Front Cardiovasc Med ; 9: 833522, 2022.

Article em En | MEDLINE | ID: mdl-36110418

Palavras-chave

coronary artery disease; percutaneous coronary intervention; periprocedural myocardial infarction; retrospective study; troponin

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google